Conceptio › Archive › HAL (France)
HAL (France)open access

Safety of FOLFIRI + Durvalumab +/− Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59

Camille Evrard et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
1, 0
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 322415
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.